TH
MDCO

Timber Hill’s Medicines Co MDCO Stock Holding History

Timber Hill’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-23,000
Closed -$1.13M – 2009
2017
Q1 		$1.13M Buy
+23,000
New +$1.05M 0.01% 1002
2016
Q4 		– Sell
-6,500
Closed -$245K – 2462
2016
Q3 		$245K Buy
+6,500
New +$245K ﹤0.01% 1789
2015
Q4 		– Sell
-6,500
Closed -$247K – 2564
2015
Q3 		$247K Sell
6,500
-7,600
-54% -$267K ﹤0.01% 2142
2015
Q2 		$403K Buy
+14,100
New +$393K ﹤0.01% 2018
2014
Q1 		– Sell
-9,500
Closed -$367K – 3095
2013
Q4 		$367K Sell
9,500
-7,800
-45% -$279K ﹤0.01% 2513
2013
Q3 		$580K Sell
17,300
-12,400
-42% -$395K ﹤0.01% 2341
2013
Q2 		$914K Buy
+29,700
New +$994K ﹤0.01% 2032

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Timber Hill's MDCO Position: Q2 2017 in Review

Timber Hill sold out of Medicines Co (MDCO) in Q2 2017, closing a stake of 6,476 shares — an estimated $288K sold.

Timber Hill first reported a position in MDCO in Q3 2013 and held it in 3 quarters. The position peaked at $751K in Q3 2013. 202 funds tracked by Wall St. Rank hold MDCO as of Q2 2017.

  • Timber Hill reported no remaining Medicines Co position as of Q2 2017 after selling out during the quarter.
  • Timber Hill sold 6,476 Medicines Co shares in Q2 2017, an estimated $288K.
  • Timber Hill first reported a position in Medicines Co in Q3 2013 and held it in 3 quarters.
  • Timber Hill's Medicines Co position peaked at $751K in Q3 2013.
  • 202 funds tracked by Wall St. Rank held Medicines Co as of Q2 2017.

Based on Timber Hill's 13F filing for Q2 2017, filed 9 Aug 2017.